- SciSparc to Acquire AutoMax
- SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression
- SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research
- SciSparc Granted Another Patent, Strengthening its Core Technology in Canada
- SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial
- SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure
- SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder
- SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe
- SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
- SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing
More ▼
Key statistics
On Friday, Scisparc Ltd (SPRC:NAQ) closed at 1.26, 9.57% above its 52-week low of 1.15, set on Apr 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.32 |
---|---|
High | 1.34 |
Low | 1.24 |
Bid | 1.25 |
Offer | 1.34 |
Previous close | 1.26 |
Average volume | 135.32k |
---|---|
Shares outstanding | 2.59m |
Free float | 2.59m |
P/E (TTM) | -- |
Market cap | 3.26m USD |
EPS (TTM) | -1.22 USD |
Data delayed at least 15 minutes, as of May 03 2024 20:59 BST.
More ▼